Cleared Special

K201271 - Benchmark BMX96 Access System

K201271 is the FDA 510(k) clearance for Benchmark BMX96 Access System by Penumbra, Inc.. It is a Class 2 Neurology device (product code DQY) cleared through the Special 510(k) pathway after a 30-day FDA review.

K201271 · Penumbra, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
30d
Days
Class 2
Risk

K201271 is an FDA 510(k) clearance for the Benchmark BMX96 Access System. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Penumbra, Inc. (Alameda, US). The FDA issued a Cleared decision on June 11, 2020 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Penumbra, Inc. devices

Submission Details

510(k) Number K201271 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 12, 2020
Decision Date June 11, 2020
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 148d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K201271.
Attain Select II + SureValve delivery catheter system, Attain Command + SureValve Left Heart Delivery System, Attain Comman + SureValve Guide Catheters for Left Heart Delivery, C315 Delivery Catheter
K192712 · Medtronic, Inc. · Aug 2020
BOBBY Balloon Guide Catheter
K193607 · MicroVention, Inc. · Jul 2020
Twin-Pass Dual Access Catheter
K193119 · Vascular Solutions, LLC · Jun 2020
Agilis HisPro Steerable Catheter With Electrodes
K200721 · Abbott (St. Jude Medical) · Jun 2020
Support Catheter
K200317 · Qxmedical, LLC · May 2020
XO Cross Support Catheter
K193420 · Transit Scientific · May 2020